Research Awards to Fund Innovative Vision Science
BrightFocus Editorial Staff
Clarksburg, MD—BrightFocus Foundation, a premier private funder of vision research, today announced a request for proposals for projects supported through its Macular Degeneration Research program. The deadline for Letters of Intent is July 29, 2021 for projects beginning in 2022.
The grants cover a wide range of investigator-initiated topics to better understand, treat, and prevent age-related macular degeneration, a leading cause of blindness. With a strong emphasis on early career scientists and their new ideas, BrightFocus offers three levels of grants:
BrightFocus funding has blazed new trails of discovery, including breakthroughs that have led to multiple Nobel Prizes. “We encourage scientists from around the world to bring us their bold, high-impact ideas, the ‘what-if’s’ of science that may someday help save sight,” said Diane Bovenkamp, PhD, BrightFocus Vice President for Scientific Affairs.
Visit here for more information about the BrightFocus macular degeneration grants, including how to apply. Our most recent yearbook gives an overview of scientific projects the program is currently supporting around the globe.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus President and CEO Stacy Pagos Haller spoke with WebMD's Chief Medical Officer John Whyte, MD, MPH, as part of its “Champions for Change” series to discuss the progress being made to advance the understanding of geographic atrophy, which affects around 1 million people in the U.S.
BrightFocus Foundation, in partnership with three other global vision loss advocacy organizations, has declared Dec. 5 as World Geographic Atrophy Day.
BrightFocus Foundation’s second Macular Fast Track program will train promising graduate students, postdoctoral fellows, and other early-career scientists to help speed progress toward a cure for macular degeneration.
Annual awards recognize top-ranked grant recipients whose proposals show great promise to prevent, treat, and cure macular degeneration and glaucoma.
In recognition of Macular Degeneration Awareness Month, BrightFocus Foundation offers a variety of free educational resources to help individuals with macular degeneration and their loved ones navigate the disease.
